DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMILOMOTIDE
2
Protein
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
AMILOMOTIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
31830Y299X
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABT-072
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
ABT-072
×
Maximum Phase:
2
First Approval:
None
UNII:
PSQ4R5K1QI
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O5S
Molecular Weight:
469.56
AlogP:
3.37
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
6.0
Source:
FROVOCIMAB
2
Antibody
Investigational
Unknown
Unknown
Hyperlipidemias; Hypercholesterolemia
Subtilisin/kexin type 9 inhibitor
FROVOCIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
87PZ955YRB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAF-265
2
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
RAF-265
×
Maximum Phase:
2
First Approval:
None
UNII:
8O434L3768
Molecule Type:
Small molecule
Molecular Formula:
C24H16F6N6O
Molecular Weight:
518.42
AlogP:
6.93
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BALTALEUCEL-T
2
Cell
Investigational
Unknown
Unknown
Lymphoma
Unknown
BALTALEUCEL-T
×
Maximum Phase:
2
First Approval:
None
UNII:
F9670LP52I
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06459988
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
PF-06459988
×
Maximum Phase:
2
First Approval:
None
UNII:
5IE92SK9EB
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN7O3
Molecular Weight:
431.88
AlogP:
2.13
PSA:
110.19
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GTS-21
2
Small molecule
Investigational
Unknown
Unknown
Autistic Disorder; Obesity; Alzheimer Disease; Psychotic Disorders; Schizophrenia; Tobacco Use Disorder
Unknown
GTS-21
×
Maximum Phase:
2
First Approval:
None
UNII:
8S399XDN2K
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O2
Molecular Weight:
308.38
AlogP:
3.77
PSA:
43.71
HBD:
0.0
HBA:
#RotB:
4.0
Source:
RISLENEMDAZ
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
RISLENEMDAZ
×
Maximum Phase:
2
First Approval:
None
UNII:
5HAM167S5T
Molecule Type:
Small molecule
Molecular Formula:
C19H23FN4O2
Molecular Weight:
358.42
AlogP:
3.19
PSA:
67.35
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TEZAMPANEL
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Glutamate receptor ionotropic AMPA antagonist
TEZAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
GA36S2O9C2
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O2
Molecular Weight:
279.34
AlogP:
0.61
PSA:
103.79
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DM-CHOC-PEN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DM-CHOC-PEN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DALOTUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Multiple Myeloma; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neuroendocrine Tumors; Rectal Neoplasms
Insulin-like growth factor I receptor antagonist
DALOTUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
6YI1L648RH
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CGC-11047
2
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CGC-11047
×
Maximum Phase:
2
First Approval:
None
UNII:
2C4Y86R2AX
Molecule Type:
Small molecule
Molecular Formula:
C14H32N4
Molecular Weight:
256.44
AlogP:
0.72
PSA:
48.12
HBD:
4.0
HBA:
#RotB:
14.0
Source:
KALLIKREIN-1
2
Unknown
Investigational
Unknown
Unknown
Stroke; Cerebrovascular Disorders; Ischemic Stroke
Unknown
KALLIKREIN-1
×
Maximum Phase:
2
First Approval:
None
UNII:
JNG5AC5YGW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REZATOMIDINE
2
Small molecule
Investigational
Unknown
Unknown
Cystitis, Interstitial; Diabetic Neuropathies; Fibromyalgia; Irritable Bowel Syndrome
Unknown
REZATOMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W5LMZ0RC8I
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2S
Molecular Weight:
232.35
AlogP:
3.84
PSA:
31.58
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GISADENAFIL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Erectile Dysfunction; Prostatic Hyperplasia; Urinary Bladder, Overactive
Phosphodiesterase 5A inhibitor
GISADENAFIL
×
Maximum Phase:
2
First Approval:
None
UNII:
S6G4R7DI1C
Molecule Type:
Small molecule
Molecular Formula:
C23H33N7O5S
Molecular Weight:
519.63
AlogP:
1.12
PSA:
135.54
HBD:
1.0
HBA:
#RotB:
10.0
Source:
AV-101
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Depressive Disorder; Depressive Disorder, Major
Glutamate [NMDA] receptor antagonist
AV-101
×
Maximum Phase:
2
First Approval:
None
UNII:
77XLH9L40B
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClN2O3
Molecular Weight:
242.66
AlogP:
0.91
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
FISPEMIFENE
2
Small molecule
Investigational
Unknown
Unknown
Erectile Dysfunction; Hypogonadism; Sexual Dysfunction, Physiological
Estrogen receptor modulator
FISPEMIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
3VZ2833V08
Molecule Type:
Small molecule
Molecular Formula:
C26H27ClO3
Molecular Weight:
422.95
AlogP:
5.66
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
11.0
Source:
ORP-101
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome
Kappa opioid receptor antagonist
ORP-101
×
Maximum Phase:
2
First Approval:
None
UNII:
SE6KE496VO
Molecule Type:
Small molecule
Molecular Formula:
C60H84N2O8
Molecular Weight:
961.34
AlogP:
9.19
PSA:
102.32
HBD:
2.0
HBA:
#RotB:
13.0
Source:
ZALUNFIBAN
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease; ST Elevation Myocardial Infarction
Unknown
ZALUNFIBAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5XQC91CO1F
Molecule Type:
Small molecule
Molecular Formula:
C16H18N8O2S
Molecular Weight:
386.44
AlogP:
-0.48
PSA:
130.54
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CBLB502
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CBLB502
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RONICICLIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Small Cell Lung Carcinoma
Cyclin-dependent kinase inhibitor
RONICICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0W9Q8U337A
Molecule Type:
Small molecule
Molecular Formula:
C18H21F3N4O3S
Molecular Weight:
430.45
AlogP:
3.96
PSA:
108.19
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GSK-2245035
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Toll-like receptor 7 agonist
GSK-2245035
×
Maximum Phase:
2
First Approval:
None
UNII:
5L3SX16QBQ
Molecule Type:
Small molecule
Molecular Formula:
C20H34N6O2
Molecular Weight:
390.53
AlogP:
2.93
PSA:
102.06
HBD:
2.0
HBA:
#RotB:
10.0
Source:
XL-281
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Thyroid Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
XL-281
×
Maximum Phase:
2
First Approval:
None
UNII:
DW2NWI3TFN
Molecule Type:
Small molecule
Molecular Formula:
C24H19ClN4O4
Molecular Weight:
462.89
AlogP:
4.56
PSA:
107.55
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FARGLITAZAR
2
Small molecule
Investigational
Unknown
Unknown
Liver Cirrhosis
Peroxisome proliferator-activated receptor gamma agonist
FARGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
3433GY7132
Molecule Type:
Small molecule
Molecular Formula:
C34H30N2O5
Molecular Weight:
546.62
AlogP:
6.61
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
12.0
Source:
TBI-1401
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TBI-1401
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TILPISERTIB
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
TILPISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C33H33ClN8O
Molecular Weight:
593.13
AlogP:
6.37
PSA:
113.45
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SGS742
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SGS742
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GALLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GALLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
632XD903SP
Molecule Type:
Small molecule
Molecular Formula:
C7H6O5
Molecular Weight:
170.12
AlogP:
0.5
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
1.0
Source:
C11-SODIUM ACETATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
C11-SODIUM ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAZLITORAN
2
Unknown
Investigational
Unknown
Unknown
Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia; Dermatomyositis; Psoriasis
Unknown
BAZLITORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
2U46M95B5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
[18F]FLUOROMISONIDAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
[18F]FLUOROMISONIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8MSY49469G
Molecule Type:
Small molecule
Molecular Formula:
C6H8FN3O3
Molecular Weight:
188.15
AlogP:
0.12
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IMO-2055
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IMO-2055
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM SILICATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MAGNESIUM SILICATE
×
Maximum Phase:
2
First Approval:
None
UNII:
9B9691B2N9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ODALASVIR
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Renal Insufficiency; Hepatitis C, Chronic
Nonstructural protein 5A inhibitor
ODALASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
OVR52K7BDW
Molecule Type:
Small molecule
Molecular Formula:
C60H72N8O6
Molecular Weight:
1001.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEXTROMETHADONE
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Restless Legs Syndrome; Depressive Disorder, Major
Unknown
DEXTROMETHADONE
×
Maximum Phase:
2
First Approval:
None
UNII:
S95RZH8AMH
Molecule Type:
Small molecule
Molecular Formula:
C21H27NO
Molecular Weight:
309.45
AlogP:
4.29
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
7.0
Source:
1
2
…
162
163
164
165
166
167
168
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA